Celator(R) Pharmaceuticals to Present on Liposome Delivery Systems at 2014 American Association of Pharmaceutical Scientists Annual Meeting
October 30, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock
October 28, 2014 10:48 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
Celator(R) Pharmaceuticals Announces Phase 3 Clinical Study of CPX-351 Achieved Target Enrollment in High Risk (Secondary) Acute Myeloid Leukemia
October 27, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products...
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public Offering of Common Stock and Warrants to Purchase Common Stock
October 23, 2014 07:00 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
Celator(R) Pharmaceuticals Announces Public Offering of Common Stock and Warrants to Purchase Common Stock
October 17, 2014 12:57 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Oct. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals to Present at BioCentury's 21st Annual NewsMakers in the Biotech Industry Conference
September 19, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Sept. 19, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell on September 17, 2014
September 17, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...
Celator(R) Pharmaceuticals Announces Publication of Preclinical Data for CPX-351 in Acute Lymphoblastic Leukemia Models
September 15, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Sept. 15, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
Celator(R) Pharmaceuticals Announces Appointment of Michael Dougherty as Chairman of the Board
September 03, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Sept. 3, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the...
Celator(R) Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference
September 02, 2014 08:30 ET
|
Celator Pharmaceuticals, Inc.
EWING, N.J., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that...